<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04979754</url>
  </required_header>
  <id_info>
    <org_study_id>SAR Sud study one</org_study_id>
    <nct_id>NCT04979754</nct_id>
  </id_info>
  <brief_title>REnal TRansplant Outcomes After CARdiac Surgery (RETROCAR)</brief_title>
  <acronym>RETROCAR</acronym>
  <official_title>Long-term Renal Outcome After Cardiac Surgery : Impact of Previous Renal Transplantation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Bordeaux</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Bordeaux</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      In this retrospective study, the authors assess long term renal outcome in renal transplant&#xD;
      recipients after cardiac surgery with cardiopulmonary bypass, and research factors associated&#xD;
      with poor long term renal outcome.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Post-operative mortality after cardiac surgery is increased in renal transplant recipients,&#xD;
      compared with general population of cardiac surgery, or with kidney transplant recipients not&#xD;
      undergoing cardiac surgery. If the survival of this specific population is now well studied,&#xD;
      the long-term renal outcome is much less studied. Previous studies show a trend for increased&#xD;
      risk of allograft dysfunction and need for permanent dialysis. This study proposes to compare&#xD;
      long term renal outcome between renal transplant recipients and non-renal transplant&#xD;
      recipients.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 1, 2020</start_date>
  <completion_date type="Anticipated">September 1, 2021</completion_date>
  <primary_completion_date type="Anticipated">August 1, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Long-term renal outcome</measure>
    <time_frame>12 months after surgery</time_frame>
    <description>Proportion of patients meeting a composite criterion : death or permanent dialysis or doubling the baseline serum creatinine value</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Glomerular Filtration Rate (GFR)</measure>
    <time_frame>30 days after surgery</time_frame>
    <description>Glomerular Filtration Rate (GFR) calculated with CKD-EPI formula</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Glomerular Filtration Rate (GFR)</measure>
    <time_frame>12 months after surgery</time_frame>
    <description>Glomerular Filtration Rate (GFR) calculated with CKD-EPI formula</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Vital status</measure>
    <time_frame>12 months after surgery</time_frame>
    <description>Mortality after surgery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Major Adverse Kidney Events</measure>
    <time_frame>Up to 12 months after surgery</time_frame>
    <description>Major Adverse Kidney Events defined by new receipt of Renal replacement therapy (RRT), or Acute Kidney Injury (AKI) episodes with persistent renal dysfunction and final serum creatinine value before hospital discharge ≥ 200 % of the baseline serum creatinine</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">86</enrollment>
  <condition>Cardiac Surgery</condition>
  <condition>Cardiopulmonary Bypass</condition>
  <condition>Renal Transplant Recipient</condition>
  <arm_group>
    <arm_group_label>RENAL TRANSPLANT RECIPIENTS</arm_group_label>
    <description>All patients with previous renal transplantation undergoing cardiac surgery with cardiopulmonary bypass</description>
  </arm_group>
  <arm_group>
    <arm_group_label>NON RENAL TRANSPLANT RECIPIENTS</arm_group_label>
    <description>All patients without previous renal transplantation undergoing cardiac surgery with cardiopulmonary bypass</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>standard of care</intervention_name>
    <description>retrospective study : standard of care</description>
    <arm_group_label>NON RENAL TRANSPLANT RECIPIENTS</arm_group_label>
    <arm_group_label>RENAL TRANSPLANT RECIPIENTS</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Consecutive renal transplant récipients, apparied in a 1:2 ratio with non renal transplant&#xD;
        récipients, undergoing cardiac surgery, and meeting the protocol criteria between january&#xD;
        2010 and december 2019, in university hospital of Bordeaux.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria for Renal Transplant Recipients group:&#xD;
&#xD;
          -  Previous renal transplantation&#xD;
&#xD;
          -  Who underwent cardiac surgery with CPB&#xD;
&#xD;
        Inclusion Criteria for Non Renal Transplant Récipients group:&#xD;
&#xD;
          -  No previous renal transplantation&#xD;
&#xD;
          -  Who underwent cardiac surgery with CPB&#xD;
&#xD;
          -  Apparied with Renal Transplant récipients with the 5 following criteria : age, sex,&#xD;
             previous diagnosis of diabete, type of cardiac surgery (isolated coronary artery&#xD;
             bypass graft, valvular surgery, aorta surgery, combined surgery), best glomerular&#xD;
             filtration rate with CKD-EPI formula at +/- 15 ml/min, in the 3 pre-operative months&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients requiring mechanical circulatory support (Extracorporeal Membrane&#xD;
             Oxygenation)&#xD;
&#xD;
          -  Pre-operative permanent dialysis&#xD;
&#xD;
          -  Aorta dissection extended to renal arteries&#xD;
&#xD;
          -  Non-elective surgery for infective endocarditis&#xD;
&#xD;
          -  Previous hepatic, pancreatic or cardiac transplantation&#xD;
&#xD;
          -  Death in the 30 first days after cardiac surgery&#xD;
&#xD;
          -  Patient not meeting the inclusion criteria&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Antoine Beurton, MD</last_name>
    <phone>557656866</phone>
    <phone_ext>+33</phone_ext>
    <email>antoine.beurton@chu-bordeaux.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Bordeaux University Hospital</name>
      <address>
        <city>Pessac</city>
        <zip>33604</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Antoine Beurton, MD</last_name>
      <phone>557656866</phone>
      <phone_ext>+33</phone_ext>
      <email>antoine.beurton@chu-bordeaux.fr</email>
    </contact>
    <investigator>
      <last_name>Alexandre Ouattara, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Antoine Beurton, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>July 2021</verification_date>
  <study_first_submitted>July 5, 2021</study_first_submitted>
  <study_first_submitted_qc>July 16, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">July 28, 2021</study_first_posted>
  <last_update_submitted>July 16, 2021</last_update_submitted>
  <last_update_submitted_qc>July 16, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">July 28, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University Hospital, Bordeaux</investigator_affiliation>
    <investigator_full_name>Alexandre Ouattara</investigator_full_name>
    <investigator_title>MD, PhD</investigator_title>
  </responsible_party>
  <keyword>cardiac surgery</keyword>
  <keyword>renal transplant recipient</keyword>
  <keyword>renal function</keyword>
  <keyword>acute kidney injury</keyword>
  <keyword>major adverse kidney events</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

